Literature DB >> 1098582

Single daily dose of allopurinol.

I Brewis, R M Ellis, J T Scott.   

Abstract

Allopurinol was administered to seven patients with gout to compare the effects of three different methods of administration. Allopurinol 100 mg given three times daily. Allopurinol given once daily as three 100 mg tablets. Allopurinol given once daily as a single 300 mg tablet. Allopurinol as a single dose in the morning gave as sustained control of plasma levels as did divided administration.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1098582      PMCID： PMC1006407          DOI： 10.1136/ard.34.3.256

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  6 in total

1.  The enzymatic spectrophotometric method for determination of uric acid.

Authors:  L LIDDLE; J E SEEGMILLER; L LASTER
Journal:  J Lab Clin Med       Date:  1959-12

2.  Withdrawal of allopurinol in patients with gout.

Authors:  W Y Loebl; J T Scott
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

3.  The use of SI units.

Authors:  V Wright
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

Review 4.  Human circadian rhythms.

Authors:  J N Mills
Journal:  Physiol Rev       Date:  1966-01       Impact factor: 37.312

5.  A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.

Authors:  R A Chalmers; H Krömer; J T Scott; R W Watts
Journal:  Clin Sci       Date:  1968-10       Impact factor: 6.124

6.  Enzymatic and metabolic studies with allopurinol.

Authors:  G B Elion
Journal:  Ann Rheum Dis       Date:  1966-11       Impact factor: 19.103
  6 in total
  8 in total

Review 1.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

2.  "Medical hubris".

Authors:  H Baker
Journal:  Can Med Assoc J       Date:  1979-08-18       Impact factor: 8.262

Review 3.  Long-term management of gout and hyperuricaemia.

Authors:  J T Scott
Journal:  Br Med J       Date:  1980-11-01

4.  Evaluation of once a day allopurinol administration in man.

Authors:  W J Currie; P Turmer; J H Young
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

5.  Efficacy of allopurinol in single daily dose.

Authors:  D Fraser; A H Little; W R Bartle
Journal:  Can Fam Physician       Date:  1977-01       Impact factor: 3.275

Review 6.  Risks and benefits of drugs used in the management and prevention of gout.

Authors:  P G Conaghan; R O Day
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

7.  Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects.

Authors:  Sophie L Stocker; Kenneth M Williams; Andrew J McLachlan; Garry G Graham; Richard O Day
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 8.  Allopurinol for chronic gout.

Authors:  Rakhi Seth; Alison S R Kydd; Rachelle Buchbinder; Claire Bombardier; Christopher J Edwards
Journal:  Cochrane Database Syst Rev       Date:  2014-10-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.